Publication
Sensitizing nanomedicine for platinum-resistant ovarian cancer.
Diana Hsin-Yu Lee, William Lee, Horacio Bach
Nanomedicine (London, England)Sep 28, 2026PMID 42802703doi:10.1080/17435889.2026.2738705 Journal ArticleReviewpubmedProvenance
- Source
- PubMed
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260929-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
Ovarian cancer is the deadliest gynecologic malignancy globally, partly due to its nonspecific presentation resulting in late diagnosis. Early in treatment, platinum drugs such as cisplatin are the main chemotherapeutic choice. Unfortunately, with repeated exposure, cancer cells frequently develop…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Ovarian Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available
No curated evidence item cites this publication.